These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diagnosis of cure in Cushing's syndrome: lessons from long-term follow-up. Barahona MJ; Resmini E; Sucunza N; Webb SM Front Horm Res; 2010; 38():152-157. PubMed ID: 20616506 [TBL] [Abstract][Full Text] [Related]
24. Lack of functional remission in Cushing's syndrome. Vermalle M; Alessandrini M; Graillon T; Paladino NC; Baumstarck K; Sebag F; Dufour H; Brue T; Castinetti F Endocrine; 2018 Sep; 61(3):518-525. PubMed ID: 30019306 [TBL] [Abstract][Full Text] [Related]
25. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease. Sonino N; Fava GA; Belluardo P; Girelli ME; Boscaro M Horm Res; 1993; 39(5-6):202-6. PubMed ID: 8314204 [TBL] [Abstract][Full Text] [Related]
26. Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission. Ragnarsson O; Stomby A; Dahlqvist P; Evang JA; Ryberg M; Olsson T; Bollerslev J; Nyberg L; Johannsson G Psychoneuroendocrinology; 2017 Aug; 82():117-125. PubMed ID: 28544904 [TBL] [Abstract][Full Text] [Related]
27. Morbidity of Cushing's Syndrome and Impact of Treatment. Webb SM; Valassi E Endocrinol Metab Clin North Am; 2018 Jun; 47(2):299-311. PubMed ID: 29754633 [TBL] [Abstract][Full Text] [Related]
28. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Kelly WF; Kelly MJ; Faragher B Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337 [TBL] [Abstract][Full Text] [Related]
29. Cushing's Syndrome and Psychosis: A Case Report and Literature Review. Fujii Y; Mizoguchi Y; Masuoka J; Matsuda Y; Abe T; Anzai K; Kunitake Y; Tateishi H; Inaba T; Murakawa T; Kato TA; Monji A Prim Care Companion CNS Disord; 2018 Sep; 20(5):. PubMed ID: 30256544 [TBL] [Abstract][Full Text] [Related]
30. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405 [TBL] [Abstract][Full Text] [Related]
36. Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission. Stomby A; Salami A; Dahlqvist P; Evang JA; Ryberg M; Bollerslev J; Olsson T; Johannsson G; Ragnarsson O Eur J Endocrinol; 2019 May; 180(5):329-338. PubMed ID: 30939453 [TBL] [Abstract][Full Text] [Related]
37. Cognitive function in patients with Cushing syndrome: a longitudinal perspective. Dorn LD; Cerrone P Clin Nurs Res; 2000 Nov; 9(4):420-40. PubMed ID: 11881698 [TBL] [Abstract][Full Text] [Related]
38. Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission. Ragnarsson O; Glad CA; Berglund P; Bergthorsdottir R; Eder DN; Johannsson G J Clin Endocrinol Metab; 2014 Sep; 99(9):E1803-7. PubMed ID: 24915124 [TBL] [Abstract][Full Text] [Related]
39. Quality of Life in Cushing's disease: A long term issue? Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700 [TBL] [Abstract][Full Text] [Related]
40. Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. Sonino N; Fava GA CNS Drugs; 2001; 15(5):361-73. PubMed ID: 11475942 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]